User:Mr. Ibrahem/Trandolapril
Clinical data | |
---|---|
Trade names | Mavik, others |
AHFS/Drugs.com | Monograph |
MedlinePlus | a697010 |
Routes of administration | By mouth |
Drug class | ACE inhibitor[1] |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Protein binding | Trandolapril 80% (independent of concentration) Trandolaprilat 65 to 94% (concentration-dependent) |
Metabolism | Liver |
Elimination half-life | 6 hours (trandolapril) 10 hours (trandolaprilat) |
Excretion | Fecal and Kidney |
Identifiers | |
| |
Chemical and physical data | |
Formula | C24H34N2O5 |
Molar mass | 430.545 g·mol−1 |
3D model (JSmol) | |
Melting point | 119 to 123 °C (246 to 253 °F) |
| |
| |
(verify) |
Trandolapril, sold under the brand name Mavik among others, is a medication used to treat high blood pressure, heart failure, and diabetic kidney disease.[1] It is one of a number of first line agents for high blood pressure.[1] It is taken by mouth.[1]
Common side effects include cough, diarrhea, and dizziness.[1] Other side effects may include high blood potassium, angioedema, kidney problems, low blood pressure, and liver problems.[1] Use during pregnancy may harm the baby.[1] It is an ACE inhibitor.[1]
Trandolapril was patented in 1981, and approved for medical use in 1993.[2] It is available as a generic medication.[3] In the United Kingdom 4 weeks of treatment costs the NHS about £2.60.[3] This amount in the United States costs about 11 USD.[4]
References[edit]
- ^ a b c d e f g h i j "Trandolapril Monograph for Professionals". Drugs.com. Archived from the original on 6 March 2021. Retrieved 8 October 2021.
- ^ Fischer J, Ganellin CR (2006). Analogue-based Drug Discovery. John Wiley & Sons. p. 469. ISBN 9783527607495. Archived from the original on 2021-08-29. Retrieved 2021-01-06.
- ^ a b BNF (80 ed.). BMJ Group and the Pharmaceutical Press. September 2020 – March 2021. p. 185. ISBN 978-0-85711-369-6.
{{cite book}}
: CS1 maint: date format (link) - ^ "Trandolapril Prices, Coupons & Savings Tips - GoodRx". GoodRx. Retrieved 8 October 2021.